Tom O'Brien

Tom O'Brien is a skilled Senior Director of Translational Oncology at Pfizer, where they lead initiatives in early development and immuno-oncology. With previous roles encompassing positions like Director and Senior Scientist at Genentech, Tom has directed significant cancer research projects and managed large-scale collaborations. Their foundational experience includes serving as a Scientist and Senior Scientist at Sunesis Pharmaceuticals, focusing on lead optimization and mechanism of action studies. Tom is currently pursuing a Ph.D. in Genetics and Development at Cornell University and has an extensive academic background, including a B.A. from Trinity College Dublin and a PostDoc from UC Berkeley.